The Wegovy Paradox: Cheaper, Yet Still Out of Reach for Many

The Great Surge: Emcure Pharma Bets Big on the Future of Weight Loss

The Hollywood Slimdown: Brooks Nader's Honest Confession and the Price of Perfection

The Weight of Expectation: Hims & Hers Eyes a Major Leap into the GLP-1 Arena

The Game Changer? America's FDA Just Gave the Nod to an Oral Weight Loss Drug, But What's the Catch?

Beyond the Syringe: Can a New Pill Finally Offer a Gentler Path in the Battle Against Obesity?

Viking Therapeutics Nears Major Milestone for Game-Changing Oral Obesity Pill

Eli Lilly Unveils $1 Billion India Investment to Supercharge Mounjaro Production

Ozempic's Arrival: Decoding India's Next Big Bet in Weight Management and Diabetes Care

Ozempic Arrives in India: A New Dawn for Type 2 Diabetes Management and Weight Loss

Chrissy Teigen's Candid Revelation: Ozempic, the Unexpected Lifeline from Deep Depression

The Unseen Challenge: Why So Many Are Halting Their Semaglutide Weight Loss Journey